Acorda Therapeutics Inc Current ratio
Cos'è Current ratio di Acorda Therapeutics Inc?
Current ratio di Acorda Therapeutics Inc è 0.33
Qual è la definizione di Current ratio?
Il rapporto corrente è un rapporto di liquidità che misura se una società dispone o meno di risorse sufficienti per soddisfare i suoi obblighi a breve termine.
The current ratio is an indication of a company's liquidity and measures the capability to meet a company's short-term obligations. It compares a firm's current assets to its current liabilities, and is expressed as current assets divided by current liabilities. The ratio is only useful when two companies are compared within industry because inter industry business operations differ substantially. To determine liquidity, the current ratio is not as helpful as the quick ratio, because it includes all those assets that may not be easily liquidated, like prepaid expenses and inventory.
Acceptable current ratios vary from industry to industry. In many cases an investor would consider a high current ratio to be better than a low current ratio, because a high current ratio indicates that the company is more likely to pay the investor back. Large current ratios are not always a good sign for investors. If the company's current ratio is too high it may indicate that the company is not efficiently using its current assets or its short-term financing facilities. If current liabilities exceed current assets the current ratio will be less than 1. A current ratio of less than 1 indicates that the company may have problems meeting its short-term obligations.
Some types of businesses can operate with a current ratio of less than one however. If inventory turns into cash much more rapidly than the accounts payable become due, then the firm's current ratio can comfortably remain less than one. Inventory is valued at the cost of acquiring it and the firm intends to sell the inventory for more than this cost. The sale will therefore generate substantially more cash than the value of inventory on the balance sheet. Low current ratios can also be justified for businesses that can collect cash from customers long before they need to pay their suppliers.
Current ratio di aziende nel Health Care settore su NASDAQ rispetto a Acorda Therapeutics Inc
Cosa fa Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Aziende con current ratio simili a Acorda Therapeutics Inc
- Canada Cobalt Works ha Current ratio di 0.33
- Social Capital Hedosophia III ha Current ratio di 0.33
- STARAMBA SE ha Current ratio di 0.33
- Piccadily Sugar & Allied Industries ha Current ratio di 0.33
- Luzhou Bank Co ha Current ratio di 0.33
- Basellandschaftliche Kantonalbank ha Current ratio di 0.33
- Acorda Therapeutics Inc ha Current ratio di 0.33
- Puxin ha Current ratio di 0.33
- China Maple Leaf Educational Systems ha Current ratio di 0.33
- PT International Development ha Current ratio di 0.33
- Itissalat Al-Maghrib (IAM) S.A ha Current ratio di 0.33
- New Providence Acquisition ha Current ratio di 0.33
- NeXR Technologies SE ha Current ratio di 0.33